![Cerus Corporation logo](/logos/CERS.webp)
Cerus Corporation
NASDAQ:CERS
Overview | Financials
Company Name | Cerus Corporation |
Symbol | CERS |
Currency | USD |
Price | 2.02 |
Market Cap | 374,299,940 |
Dividend Yield | 0% |
52-week-range | 1.21 - 2.59 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. William M. Greenman |
Website | https://www.cerus.com |
An error occurred while fetching data.
About Cerus Corporation
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD